First adaptive clinical trial for flu
European Pharmaceutical Review
NOVEMBER 29, 2022
million, UK-wide adaptive platform trial (APT) has been launched to find effective treatments for people hospitalised with severe flu for the first time, testing multiple options simultaneously in thousands of people then modifying treatments quickly. National Institute for Health and Care Research (NIHR)’s Clinical Research Network.
Let's personalize your content